neratinib fulvestrant trastuzumab for hr her2-mutant mbc and neratinib trastuzumab for tr...
Published 2 years ago • 88 plays • Length 4:52Download video MP4
Download video MP3
Similar videos
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
21:00
gs4 10 neratinib fulvestrant trastuzumab for hormone receptor-positive, her2-mutant metastatic
-
7:30
neratinib plus fulvestrant for her2 mutant, non-amplified metastatic breast cancer
-
6:34
neoadjuvant therapy with neratinib plus trastuzumab in locally advanced her2-positive breast cancer
-
1:02
dr. mohammad jahanzeb on neratinib and trastuzumab in her2-positive breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
2:00
neratinib after trastuzumab-based adjuvant therapy in her 2 positive breast cancer (extenet)
-
5:26
trastuzumab deruxtecan shows benefit in patients with her2 mbc
-
1:20
final results from the phase 2 summit basket trial: targeting her2 advanced btcs with neratinib
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
0:59
dr. linda vahdat on frontline eribulin plus trastuzumab in her2-positive mbc
-
1:53
optimal timing for neratinib
-
8:47
sramila aithal, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
6:46
neratinib in mbc with her2 activating mutations
-
4:05
camizestrant may be superior to fulvestrant in patients with hr-positive, her2-negative bc